局部晚期宫颈癌患者接受新辅助治疗后根治性手术的健康相关生活质量:一项基于前瞻性数据库的单中心回顾性研究
该单中心回顾性研究基于前瞻性数据库,纳入275例FIGO IB2-IIIB期接受新辅助同步放化疗或单纯放疗后行根治性手术的局部晚期宫颈癌患者,用EORTC QLQ-C30和QLQ-CX24在治疗前和术后6个月评估健康相关生活质量。结果显示两组躯体功能和角色功能均有改善,RT+RS组在生活质量、躯体功能和社会功能上优于CCRT+RS组,但两组绝经症状均加重,CCRT+RS组淋巴水肿加重,RT+RS组性担忧加重。作者认为RT+RS组总体健康相关生活质量更好,但需进一步前瞻性随机临床试验验证。
要点
- 术后6个月两组躯体功能和角色功能均较基线改善。
- RT+RS组生活质量、躯体功能和社会功能优于CCRT+RS组。
- 两组绝经症状加重,CCRT+RS组淋巴水肿加重,RT+RS组性担忧加重。
核心结论
- 新辅助CCRT或单纯RT后行RS的局部晚期宫颈癌患者术后6个月QLQ-C30功能和肿瘤相关症状评分改善,而淋巴水肿和绝经症状加重。
- RT+RS组总体健康相关生活质量优于CCRT+RS组,但需进一步前瞻性随机临床试验验证。
研究设计与样本
- 单中心回顾性研究,基于前瞻性数据库,纳入275例FIGO IB2-IIIB期接受CCRT/RT+RS的局部晚期宫颈癌患者。
- 采用EORTC QLQ-C30和EORTC QLQ-CX24在治疗前(基线)和术后6个月前瞻性评估健康相关生活质量。
主要发现
- 接受CCRT+RS或RT+RS的患者随访时躯体功能(P < 0.001)和角色功能(P = 0.002,P = 0.031)有统计学显著且临床相关的改善。
- 治疗后RT+RS组生活质量、躯体功能和社会功能优于CCRT+RS组(P = 0.028,P = 0.010,P = 0.014)。
- 两组疲劳症状评分随时间下降(P < 0.001,P = 0.004),失眠仅在RT+RS组下降(P = 0.042)。
- 随访时两组绝经症状均加重(P = 0.001,P = 0.047),淋巴水肿仅在CCRT+RS组加重(P < 0.001)。
- 性功能评分组间及随时间无差异,但性担忧在RT+RS组加重(P = 0.042)。
局限性
- 原文结论指出需进一步前瞻性随机临床试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the health-related quality of life (HRQOL) in locally advanced cervical cancer (LACC) patients treated with neoadjuvant concurrent chemoradiation (CCRT) or radiation (RT) alone followed by radical surgery (RS). METHODS: In a single-center retrospective study from a prospective database, 275 FIGO Stage IB2-IIIB patients who underwent CCRT/RT + RS were included. HRQOL was prospectively assessed by EORTC QLQ-C30 and EORTC QLQ-CX24 prior to any treatment (baseline) and 6 months after surgery, respectively. RESULTS: A statistically significant and clinically relevant improvement in physical functioning (P < 0.001) and role functioning (P = 0.002, P = 0.031) was observed in patients receiving either CCRT+RS or RT + RS at follow-up. In addition, quality of life (QoL), physical functioning, and social functioning were better in the RT + RS group than the CCRT+RS group after treatment (P = 0.028, P = 0.010, P = 0.014). Symptom scores of fatigue decreased in both groups over time (P < 0.001, P = 0.004) while insomnia decreased only in the RT + RS group (P = 0.042). Worsened menopausal symptoms were documented in both groups at follow-up (P = 0.001, P = 0.047), while lymphedema was deteriorated only in patients receiving CCRT + RS (P < 0.001). Sexuality scores did not differ between groups or over time with the exception of sexual worry, which was deteriorated in patients receiving RT + RS (P = 0.042). CONCLUSIONS: QLQ-C30 functioning and tumor-related symptoms scores improved while lymphedema and menopausal symptoms worsened 6 months after neoadjuvant CCRT or RT alone followed by RS in LACC patients. Patients treated with RT + RS had a generally better HRQOL compared with those receiving CCRT+RS, though further validation with prospective randomized clinical trials is warranted.
引用
- Liu B, Li L, Wang M, et al. Health-related quality of life in locally advanced cervical cancer patients treated with neoadjuvant therapy followed by radical surgery: A single-institutional retrospective study from a prospective database. Gynecol Oncol. 2019. PMID: 31307665. doi:10.1016/j.ygyno.2019.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。